EUVIMEDEUVIMED entdecken
Crossref

Vitamin D and hematologic malignancies: A comprehensive review of its role in therapeutic potential, pathogenesis, and prognosis

Abolfazl Jalilvand, Mohammadhossein Kouhpaeenejad, Leila Faeli, Nesa Rashidi

Biomedicine Advances · 27.04.2026 · 3 (2) · 64-71

DOI: 10.34172/bma.63 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedicine Advances, online erschienen am 27.04.2026. Verfasst von Abolfazl Jalilvand und 3 weiteren Autor:innen. Die Arbeit nennt 76 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D has immunomodulatory, anti-proliferative, and pro-differentiative effects that are increasingly linked to hematologic malignancies, beyond its traditional function in maintaining calcium-phosphate balance. Patients with leukemia and lymphoma frequently have vitamin D deficiency, which has been linked to poor prognostic characteristics and a lower chance of survival. The active metabolite 1,25-dihydroxyvitamin D3 stimulates cellular differentiation, suppresses proliferation, and triggers apoptosis in acute leukemias (ALL and AML) by means of vitamin D receptor (VDR)-mediated transcriptional regulation. Based on empirical evidence, a higher tumor burden, a worse response to treatment, and an advanced disease stage are all associated with low vitamin D levels in chronic leukemias (CLL and CML). Similarly, hypovitaminosis D has been associated with worse treatment outcomes for both Hodgkin and non-Hodgkin lymphomas. By modifying cytokine production, immune cell function, angiogenesis, cell cycle regulation, and tumor–microenvironment interactions, vitamin D mechanistically affects leukemogenesis and lymphomagenesis. This review outlines the most recent molecular and clinical data that suggests vitamin D may be used as a prognostic biomarker and an adjuvant therapeutic target in hematologic malignancies. However, to elucidate its therapeutic impact and clinical utility, extensive prospective and randomized studies are needed.

Zitieren

APA

Jalilvand, A., Kouhpaeenejad, M., Faeli, L., & Rashidi, N. (2026). Vitamin D and hematologic malignancies: A comprehensive review of its role in therapeutic potential, pathogenesis, and prognosis. Biomedicine Advances, 3(2), 64-71. https://doi.org/10.34172/bma.63

Vancouver

Jalilvand A, Kouhpaeenejad M, Faeli L, Rashidi N. Vitamin D and hematologic malignancies: A comprehensive review of its role in therapeutic potential, pathogenesis, and prognosis. Biomedicine Advances. 2026;3(2):64-71. doi:10.34172/bma.63

BibTeX
@article{Jalilvand2026,
  author = {Jalilvand, Abolfazl and Kouhpaeenejad, Mohammadhossein and Faeli, Leila and Rashidi, Nesa},
  title = {Vitamin D and hematologic malignancies: A comprehensive review of its role in therapeutic potential, pathogenesis, and prognosis},
  journal = {Biomedicine Advances},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {64--71},
  doi = {10.34172/bma.63}
}
Kostenlos starten →